ALX Oncology Holdings Inc (ALXO) stock
ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00+0.00 (+0.50%)
Close on Nov 17, 2026Market cap $138.97MP/E –Yield –
ALX Oncology operating margin
Operating margin is operating income as a percentage of revenue.
ALX Oncology's operating margin for the twelve months ending Dec 31, 2020 was -3694.0%. For fiscal 2020 it was -3694.0%, against -400.0% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -3694.0% | −3294.0 |
| FY2019 | Dec 31, 2019 | -400.0% | +262.0 |
| FY2018 | Dec 31, 2018 | -662.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | -2046.9% | −1723.4 |
| Q1 FY2020 | Mar 31, 2020 | -800.3% | – |
| Q4 FY2019 | Dec 31, 2019 | -637.5% | – |
| Q3 FY2019 | Sep 30, 2019 | -241.6% | – |
| Q2 FY2019 | Jun 30, 2019 | -323.5% | – |
See a number that looks wrong?